NCT02198287View on ClinicalTrials.gov

Dose Extension Study of BIIX 1 XX in Healthy Young Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

April 30, 1999

Conditions
Healthy
Interventions
DRUG

BIIX 1 XX inhalation solution

single doses of 800, 1000, 1200, 1400, 1600, 1800, or 2000 mcg

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY